Skip to main content
Premium Trial:

Request an Annual Quote

GenoMed Applies for Amex Listing as Nasdaq OTC Plan Idles

NEW YORK, July 6 (GenomeWeb News) - GenoMed plans to move from the Pink Sheets over-the-counter market to a listing on the American Stock Exchange.


The company said today that it expects to hear from Amex about the status of its application within six to eight weeks. GenoMed's stock is currently traded on the Pink Sheets under the ticker symbol GMED.


In November 2002, GenoMed announced plans to trade on the Nasdaq over-the-counter bulletin board. David Moskowitz, CEO and chief medical officer of the company, told GenomeWeb News today that changes in accounting rules and other factors led to a number of delays in the approval process. "We never got an official denial, but we certainly didn't get an approval either," he said.


Moskowitz said the company has a good chance of meeting the primary requirement for trading on Amex -- a market capitalization of $50 million. The company has around 200 million shares outstanding, and Moskowitz said he is confident the company can hit and maintain a $0.25 share price to reach the $50 million market cap milestone.


GenoMed's stock was trading at $0.185 as of 12:30 EDT today, after opening at $0.16.


Many brokers avoid Pink Sheet stocks, Moskowitz said, so a move to Amex is expected to increase investor confidence and improve the company's liquidity.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.